Raptim Research

Raptim, a global independent and internationally accredited Clinical Research Organization (“CRO”), established in 2005, supporting the end-to-end services under the Clinical Research domain - Bioequivalence, IVRT/IVPT & BCS Biowaiver option; for all Pharmaceutical companies worldwide. Raptim stands for “Rapid” and it acts as a catalyst to hasten the regulatory submissions and approvals of customers’ products. We are market leader among independent Indian CROs, with the highest quality standards and quick turnaround times. We have a strong regulatory track record and numerous accreditation/approvals from global regulatory agencies like USFDA, WHO, ISP Chile, NABL, DCGI & product approval from MCC, CANADA. TGA, MHRA and FDA-Korea. Raptim is a technologically advanced CRO with experienced professionals who apply innovative tools and processes to their clinical development. We believe that our experience in all aspects of clinical research management; places us in a unique position to assist Sponsor with unparalleled support. Services include end to end verticals as below: • BA/BE studies • Bio analytical services (Drug, Elemental, Vitamin, Hormones etc) • Dermatology • IVRT/IVPT • CACO2 studies • Patient Pk studies • Clinical Trial (phase-II – IV) • Long housing study - Phytonadione, KCL • Data management • Medical & Scientific Writing • Complex BE Studies - Controlled substance, Inhalation, Nasal Spray, Transdermal Patch, Suppository, female contraceptive ring, Hormonal study. Headquartered & operations in Navi Mumbai, and Business offices in INDIA and USA with employee strength of 350+ of varied ethnic backgrounds providing a culturally rich working environment. Raptim has the optimized resources and the right approach to deliver the results that will make the project a success. New state of the art clinical research facility, coming soon!!